Dynamic Technology Lab Private LTD Allakos Inc. Transaction History

Dynamic Technology Lab Private LTD

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 14, 2023	SELL	$3.6 - $5.25 $37,598 - $54,831	-10,444 Reduced 28.39%	26,346 $115,000
Q1 2023 May 12, 2023	BUY	$4.3 - $8.27 $158,197 - $304,253	36,790 New	36,790 $164,000
Q2 2022 Aug 12, 2022	SELL	$2.6 - $6.14 $167,073 - $394,550	-64,259 Reduced 80.55%	15,516 $48,000
Q1 2022 May 16, 2022	BUY	$5.08 - $9.81 $405,257 - $782,592	79,775 New	79,775 $455,000
Q3 2021 Nov 15, 2021	SELL	$76.53 - $110.43 $417,853 - $602,947	-5,460 Closed	0 $0
Q2 2021 Aug 13, 2021	BUY	$85.37 - $114.1 $466,120 - $622,986	5,460 New	5,460 $466,000
Q4 2020 Feb 11, 2021	SELL	$79.58 - $152.45 $355,563 - $681,146	-4,468 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$66.43 - $90.99 $296,809 - $406,543	4,468 New	4,468 $364,000

64.7M

47.1K

Ticker ALLK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 84,726,096
Market Cap $81.3M
Description
Allakos Inc., a clinical stage biopharmaceutical company, develops therapeutics that target immunomodulatory receptors present on immune effector cells in allergy, inflammatory, and proliferative diseases. The company's lead monoclonal antibody is lirentelimab (AK002), which is in a Phase III study for the treatment of eosinophilic gastritis and...

Get notified when there are updates to the investment portfolio of Dynamic Technology Lab Private LTD, based on Form 13F filings with the SEC.

Stay updated on Dynamic Technology Lab Private LTD with notifications on news.